Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 252

1.

Glycaemic variability and its association with enteral and parenteral nutrition in critically ill ventilated patients.

Doola R, Greer RM, Hurford R, Flatley C, Forbes JM, Todd AS, Joyce CJ, Sturgess DJ.

Clin Nutr. 2018 Aug 16. pii: S0261-5614(18)31343-8. doi: 10.1016/j.clnu.2018.08.001. [Epub ahead of print]

PMID:
30170779
2.

On the Specification of Upward-Propagating Tides for ICON Science Investigations.

Forbes JM, Zhang X, Hagan ME, England SL, Liu G, Gasperini F.

Space Sci Rev. 2017 Oct;212(1-2):697-713. doi: 10.1007/s11214-017-0401-5. Epub 2017 Aug 3.

PMID:
30093735
3.

Diabetes-Specific Formulae Versus Standard Formulae as Enteral Nutrition to Treat Hyperglycemia in Critically Ill Patients: Protocol for a Randomized Controlled Feasibility Trial.

Doola R, Todd AS, Forbes JM, Deane AM, Presneill JJ, Sturgess DJ.

JMIR Res Protoc. 2018 Apr 9;7(4):e90. doi: 10.2196/resprot.9374.

4.

Mitochondrial Dysfunction and Signaling in Diabetic Kidney Disease: Oxidative Stress and Beyond.

Flemming NB, Gallo LA, Forbes JM.

Semin Nephrol. 2018 Mar;38(2):101-110. doi: 10.1016/j.semnephrol.2018.01.001. Review.

PMID:
29602393
5.

Mitochondrial dysfunction in diabetic kidney disease.

Forbes JM, Thorburn DR.

Nat Rev Nephrol. 2018 May;14(5):291-312. doi: 10.1038/nrneph.2018.9. Epub 2018 Feb 19. Review.

PMID:
29456246
6.

Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction.

Borg DJ, Yap FYT, Keshvari S, Simmons DG, Gallo LA, Fotheringham AK, Zhuang A, Slattery RM, Hasnain SZ, Coughlan MT, Kantharidis P, Forbes JM.

Islets. 2018 Jan 2;10(1):10-24. doi: 10.1080/19382014.2017.1405189. Epub 2017 Dec 22.

7.

Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes.

Ward MS, Flemming NB, Gallo LA, Fotheringham AK, McCarthy DA, Zhuang A, Tang PH, Borg DJ, Shaw H, Harvie B, Briskey DR, Roberts LA, Plan MR, Murphy MP, Hodson MP, Forbes JM.

Sci Rep. 2017 Nov 9;7(1):15190. doi: 10.1038/s41598-017-15589-x.

8.

Increased liver AGEs induce hepatic injury mediated through an OST48 pathway.

Zhuang A, Yap FY, Bruce C, Leung C, Plan MR, Sullivan MA, Herath C, McCarthy D, Sourris KC, Kantharidis P, Coughlan MT, Febbraio MA, Hodson MP, Watt MJ, Angus P, Schulz BL, Forbes JM.

Sci Rep. 2017 Sep 25;7(1):12292. doi: 10.1038/s41598-017-12548-4.

9.

Vascular complications in diabetes: old messages, new thoughts.

Forbes JM, Fotheringham AK.

Diabetologia. 2017 Nov;60(11):2129-2138. doi: 10.1007/s00125-017-4360-x. Epub 2017 Jul 19. Review.

PMID:
28725914
10.

Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial.

Baye E, de Courten MP, Walker K, Ranasinha S, Earnest A, Forbes JM, de Courten B.

Sci Rep. 2017 Jun 23;7(1):4123. doi: 10.1038/s41598-017-04214-6.

11.

A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes.

Salonen KM, Ryhänen SJ, Forbes JM, Härkönen T, Ilonen J, Simell O, Veijola R, Groop PH, Knip M.

Diabetes Metab Res Rev. 2017 May;33(4). doi: 10.1002/dmrr.2872. Epub 2017 Jan 23.

PMID:
27883367
12.

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.

Leung C, Herath CB, Jia Z, Andrikopoulos S, Brown BE, Davies MJ, Rivera LR, Furness JB, Forbes JM, Angus PW.

World J Gastroenterol. 2016 Sep 21;22(35):8026-40. doi: 10.3748/wjg.v22.i35.8026.

13.

Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.

Leung SS, Forbes JM, Borg DJ.

Curr Diab Rep. 2016 Oct;16(10):100. doi: 10.1007/s11892-016-0782-y. Review.

PMID:
27612847
14.

Targeting advanced glycation with pharmaceutical agents: where are we now?

Borg DJ, Forbes JM.

Glycoconj J. 2016 Aug;33(4):653-70. doi: 10.1007/s10719-016-9691-1. Epub 2016 Jul 9. Review.

PMID:
27392438
15.

Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.

Gallo LA, Ward MS, Fotheringham AK, Zhuang A, Borg DJ, Flemming NB, Harvie BM, Kinneally TL, Yeh SM, McCarthy DA, Koepsell H, Vallon V, Pollock C, Panchapakesan U, Forbes JM.

Sci Rep. 2016 Jul 7;6:28124. doi: 10.1038/srep28124. No abstract available.

16.

Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?

Zhuang A, Forbes JM.

Glycoconj J. 2016 Aug;33(4):645-52. doi: 10.1007/s10719-016-9693-z. Epub 2016 Jun 6. Review.

PMID:
27270766
17.

Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.

Gallo LA, Ward MS, Fotheringham AK, Zhuang A, Borg DJ, Flemming NB, Harvie BM, Kinneally TL, Yeh SM, McCarthy DA, Koepsell H, Vallon V, Pollock C, Panchapakesan U, Forbes JM.

Sci Rep. 2016 May 26;6:26428. doi: 10.1038/srep26428. Erratum in: Sci Rep. 2016 Jul 07;6:28124.

18.

Mitochondria-Power Players in Kidney Function?

Forbes JM.

Trends Endocrinol Metab. 2016 Jul;27(7):441-442. doi: 10.1016/j.tem.2016.05.002. Epub 2016 May 20. Review.

PMID:
27215468
19.

Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial.

de Courten B, de Courten MP, Soldatos G, Dougherty SL, Straznicky N, Schlaich M, Sourris KC, Chand V, Scheijen JL, Kingwell BA, Cooper ME, Schalkwijk CG, Walker KZ, Forbes JM.

Am J Clin Nutr. 2016 Jun;103(6):1426-33. doi: 10.3945/ajcn.115.125427. Epub 2016 Mar 30.

PMID:
27030534
20.

Antigen-encoding bone marrow terminates islet-directed memory CD8+ T-cell responses to alleviate islet transplant rejection.

Coleman MA, Jessup CF, Bridge JA, Overgaard NH, Penko D, Walters S, Borg DJ, Galea R, Forbes JM, Thomas R, Coates PT, Grey ST, Wells JW, Steptoe RJ.

Diabetes. 2016 May;65(5):1328-1340. doi: 10.2337/db15-1418. Epub 2016 Mar 9.

Supplemental Content

Loading ...
Support Center